Cargando…
Predictors of galcanezumab response in a real-world study of Korean patients with migraine
To assess factors associated with galcanezumab response in a real-world study of Korean patients with migraine. Predictors of the efficacy of monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor (anti-CGRP(-R) mAb) have been rarely investigated in Asians. We prospec...
Autores principales: | Kim, Seung Ae, Jang, Hyemin, Lee, Mi Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491682/ https://www.ncbi.nlm.nih.gov/pubmed/37684346 http://dx.doi.org/10.1038/s41598-023-42110-4 |
Ejemplares similares
-
Galcanezumab for migraine
Publicado: (2020) -
Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis
por: Takizawa, Tsubasa, et al.
Publicado: (2022) -
Real-life experiences with galcanezumab and predictors for treatment response in Turkey
por: Yalinay Dikmen, Pınar, et al.
Publicado: (2023) -
An Evidence-Based Review of Galcanezumab for the Treatment of Migraine
por: Urits, Ivan, et al.
Publicado: (2020) -
Photophobia and migraine outcome during treatment with galcanezumab
por: Schiano di Cola, Francesca, et al.
Publicado: (2023)